Pfizer lays a chunky bid on Wyeth

The merger of two pharma giants is the largest industry deal so far this year. Pfizer will acquire Wyeth in a cash-and-stock transaction currently valued at app...

EU grants project on toxicity of nanomaterials

A multinational research project has have been awarded EUR 3 358 500 from the European Commission to study the hazardous effects of engineered nanomaterials on ...

Samuel Lagercrantz: Collaboration and joint efforts are the key to success

Although many questions about Covid-19 remain unanswered, the development of drugs and vaccines has been incredibly rapid, writes Samuel Lagercrantz, Life Scien...

Engage with your CMO early

Gordon Hutton is Materials Science Lead at Thermo Fisher Scientific’s, formerly GSK, small molecule API site in Cork, Ireland.

Combining two drug delivery strategies to improve bioavailability

Danish researchers hope to increase the bioavailability of low solubility drugs.

Pharma Outsourcing igång på Stockholm Waterfront

IRW Consulting is seeking Clinical Research Associates (CRAs) on positions located in Stockholm

180 cancerforskare samlas digitalt i Lund

Medicon Village och Lunds universitet ordnar ett digitalt möte på Världscancerdagen på torsdag.

From spin-off to phase II

”The people there will basically become your new colleagues” – Carina Schmidt, former CEO of Athera, about working with different contractors.

Digitalisering av in vivo-data ska underlätta för forskare

Problem med stora datamängder väckte en idé hos forskaren Sara Mangsbo och hennes kollegor på Vivologica, som utvecklade en mjukvaruplattform som underlättar fö...

It´s time to establish relations

Communication with the patient is the key to future healthcare, writes Hanna Brodda, editor in chief of Life Science Sweden.

Brexit creeping closer – or?

In this column, lawyer Pernilla Norman, tries to sort out the different Brexit options.

The perfect formula for decision-making

No one has the luxury not to take a decision, writes Helena Strigård at Swedenbio.

Anna Törner: Success requires bold decisions!

“Doing things right is fine, but doing the right things as soon as possible is even better”, writes Anna Törner in a column.

Before you choose a CRO

– We are a small company and it is very important for us to maintain our core competence within development of novel nanomaterials, Tove Sivik Sonne, Head of De...

Giulia Gaudenzi: ”Key lessons from global health research”

The world will still face major challenges in the post Covid-19 pandemic, writes Giulia Gaudenzi at the KTH Division of Nanobiotechnology at Scilifelab, in a column.

Lockdown-studie kritiseras även i USA

I USA har den uppmärksammade metastudie som uppger att knappt några liv har räddats med hjälp av lockdowns blivit kraftigt ifrågasatt av forskare.

Myndigheterna till företagen: samarbeta under pandemin

Det internationella samarbetsorganet för läkemedelsmyndigheter slår ett slag för stora välgenomförda studier och samarbete mellan olika aktörer.

Brexit looking back and looking forward

More than 3 years have passed after the vote and there is still uncertainty around the outcome although the UK December 12 election set a clearer course towards...

Lucy Robertshaw: There is a bio revolution happening right now

Lucy Robertshaw is both proud and excited to be taking the baton of moderating this year’s Pharma Outsourcing event.

They’re all doing it – buying drug research

December 12 the time has come for this year's annual partnering meeting Pharma Outsourcing in Stockholm. In Sweden this is a growing business, with Recipharm as...

Visar lovande ny mekanism mot alzheimer

”Vi är nära ett genombrott i kampen mot Alzheimers sjukdom.” Det var budskapet från Pontus Forsell, forskningschef på AlzeCure, vid mötet 17th International Con...

Orsaker och prevention på möte om demens

Drottning Silvia bjöd nyligen in till det 3:e internationella stormötet Dementia Forum X 2019. Mötet samlade verksamhetsledare, beslutsfattare, forskare och kun...

Krönika: Collaboration across borders